Integrated Diagnostics Holdings (8I8) Financial Statements
Integrated Diagnostics Holdings Financial Overview
Integrated Diagnostics Holdings's market cap is currently $233.45M. The company's EPS TTM is $2.59; its P/E ratio is 9.72; and it has a dividend yield of 5.44%. Integrated Diagnostics Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.86B | $ 5.72B | $ 4.12B | $ 3.61B | $ 5.22B |
| Gross Profit | $ 3.35B | $ 2.18B | $ 1.52B | $ 1.46B | $ 2.80B |
| Operating Income | $ 2.12B | $ 1.21B | $ 737.76M | $ 832.19M | $ 2.26B |
| EBITDA | $ 2.89B | $ 2.09B | $ 1.28B | $ 1.29B | $ 2.57B |
| Net Income | $ 1.26B | $ 1.08B | $ 510.30M | $ 541.11M | $ 1.41B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.13B | $ 1.75B | $ 860.51M | $ 815.92M | $ 2.35B |
| Total Assets | $ 8.60B | $ 7.13B | $ 5.77B | $ 5.30B | $ 6.24B |
| Total Debt | $ 1.61B | $ 1.47B | $ 1.18B | $ 1.18B | $ 858.74M |
| Net Debt | $ -57.56M | $ 284.01M | $ 504.95M | $ -532.09M | $ -793.38M |
| Total Liabilities | $ 4.46B | $ 3.63B | $ 2.67B | $ 2.85B | $ 3.44B |
| Stockholders' Equity | $ 3.38B | $ 2.71B | $ 2.68B | $ 2.15B | $ 2.58B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.38B | $ 1.34B | $ 217.73M | $ -100.11M | $ 2.01B |
| Operating Cash Flow | $ 1.90B | $ 1.57B | $ 543.66M | $ 208.73M | $ 2.27B |
| Investing Cash Flow | $ -552.92M | $ -446.71M | $ -243.94M | $ 990.11M | $ -1.33B |
| Financing Cash Flow | $ -851.06M | $ -749.00M | $ -330.46M | $ -1.62B | $ -647.15M |
Currency in 67